Patents by Inventor Scott P. Falci

Scott P. Falci has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TREATING NEUROPATHIC PAIN IN SPINAL CORD INJURED INDIVIDUALS
    Publication number: 20230355508
    Abstract: Methods of treating neuropathic pain in spinal cord injured individuals by administering levetiracetam or brivaracetam are described.
    Type: Application
    Filed: March 1, 2023
    Publication date: November 9, 2023
    Inventor: Scott P. Falci
  • Treating neuropathic pain in spinal cord injured individuals
    Patent number: 11596596
    Abstract: Methods of treating neuropathic pain in spinal cord injured individuals by administering levetiracetam or brivaracetam are described.
    Type: Grant
    Filed: October 16, 2017
    Date of Patent: March 7, 2023
    Assignee: CNS BIOSCIENCES, INC.
    Inventor: Scott P. Falci
  • TREATING NEUROPATHIC PAIN IN SPINAL CORD INJURED INDIVIDUALS
    Publication number: 20190321659
    Abstract: Methods of treating neuropathic pain in spinal cord injured individuals by administering levetiracetam or brivaracetam are described.
    Type: Application
    Filed: October 16, 2017
    Publication date: October 24, 2019
    Inventor: Scott P. FALCI
  • Rodent model of central neuropathic pain caused by dorsal root entry zone avulsion at T13
    Patent number: 9452226
    Abstract: The present disclosure describes an animal model of central neuropathic pain relevant to spinal cord injury, as well as methods of using the model to screen for therapeutic agents and to test existing therapies.
    Type: Grant
    Filed: August 6, 2013
    Date of Patent: September 27, 2016
    Inventor: Scott P. Falci
  • Method for eradicating pain of central origin resulting from spinal cord injury
    Patent number: 8694107
    Abstract: Methods are provided to reliably identify and surgically eradicate aberrant DREZ in patients suffering from spinal cord injury. The methods include identifying potential aberrant DREZ using a combination of mapping techniques based on the location of the patients perceived pain, analysis of the spontaneous electrical hyperactivity in targeted DREZ, and analysis of evoked transcutaneous C-fiber stimulation both in pre-operative and operative conditions. Methods are also provided for identifying potential pain effecters in aberrant DREZ, useful in the preparation of non-invasive therapeutics for central pain characteristic of spinal cord injury.
    Type: Grant
    Filed: September 14, 2006
    Date of Patent: April 8, 2014
    Inventor: Scott P. Falci
  • Animal Model of Central Neuropathic Pain and Methods of Making and Using the Same
    Publication number: 20140041065
    Abstract: The present disclosure describes an animal model of central neuropathic pain relevant to spinal cord injury, as well as methods of using the model to screen for therapeutic agents and to test existing therapies.
    Type: Application
    Filed: August 6, 2013
    Publication date: February 6, 2014
    Inventor: Scott P. Falci
  • Rodent model of central neuropathic pain
    Patent number: 8502017
    Abstract: The present disclosure describes an animal model of central neuropathic pain relevant to spinal cord injury, as well as methods of using the model to screen for therapeutic agents and to test existing therapies.
    Type: Grant
    Filed: August 14, 2009
    Date of Patent: August 6, 2013
    Inventor: Scott P. Falci
  • ANIMAL MODEL OF CENTRAL NEUROPATHIC PAIN AND MEHTODS OF MAKING AND USING THE SAME
    Publication number: 20110229412
    Abstract: The present disclosure describes an animal model of central neuropathic pain relevant to spinal cord injury, as well as methods of using the model to screen for therapeutic agents and to test existing therapies.
    Type: Application
    Filed: August 14, 2009
    Publication date: September 22, 2011
    Inventor: Scott P. Falci
  • METHODS AND COMPOSITIONS FOR DELIVERING THERAPEUTIC AGENTS TO THE CENTRAL NERVOUS SYSTEM
    Publication number: 20100203022
    Abstract: Methods are provided for targeting therapeutic agents to an injury site within the central nervous system.
    Type: Application
    Filed: February 9, 2010
    Publication date: August 12, 2010
    Inventor: Scott P. Falci
  • Animal Model of Central Neuropathic Pain and Methods of Making and Using the Same
    Publication number: 20100040551
    Abstract: The present disclosure describes an animal model of central neuropathic pain relevant to spinal cord injury, as well as methods of using the model to screen for therapeutic agents and to test existing therapies.
    Type: Application
    Filed: August 14, 2009
    Publication date: February 18, 2010
    Inventor: Scott P. Falci
  • Method for eradicating pain of central origin resulting from spinal cord injury
    Patent number: 7130691
    Abstract: Methods are provided to reliably identify and surgically eradicate aberrant DREZ in patients suffering from spinal cord injury. The methods include identifying potential aberrant DREZ using a combination of mapping techniques based on the location of the patients perceived pain, analysis of the spontaneous electrical hyperactivity in targeted DREZ, and analysis of evoked transcutaneous C-fiber stimulation both in pre-operative and operative conditions. Methods are also provided for identifying potential pain effecters in aberrant DREZ, useful in the preparation of non-invasive therapeutics for central pain characteristic of spinal cord injury.
    Type: Grant
    Filed: August 30, 2002
    Date of Patent: October 31, 2006
    Inventor: Scott P. Falci
  • Method for eradicating pain of central origin resulting from spinal cord injury
    Publication number: 20040006376
    Abstract: Methods are provided to reliably identify and surgically eradicate aberrant DREZ in patients suffering from spinal cord injury. The methods include identifying potential aberrant DREZ using a combination of mapping techniques based on the location of the patients perceived pain, analysis of the spontaneous electrical hyperactivity in targeted DREZ, and analysis of evoked transcutaneous C-fiber stimulation both in pre-operative and operative conditions. Methods are also provided for identifying potential pain effecters in aberrant DREZ, useful in the preparation of non-invasive therapeutics for central pain characteristic of spinal cord injury.
    Type: Application
    Filed: August 30, 2002
    Publication date: January 8, 2004
    Inventor: Scott P. Falci